Geneseq Biosciences is a precision medicine company, based in Melbourne, Australia.

We specialise in developing novel genomic tests that help healthcare professionals diagnose cancer early and accurately.

Our first test, Melaseq™, detects the genomic fingerprint of malignant melanoma in blood or skin biopsy tissue.